Table 2.

Rates of inflammatory-related conditions and diagnoses with separate comparisons of middle and high hsCRP groups with the low hsCRP group.

	hsCRP groups (n=39 per group)
	Low (≤3 mg/L)	Mid (>3–20 mg/L)			High (>20 mg/L)
	Rate	Rate	OR	p	Rate	OR	p
Asthma (hx)	0.18	0.229	1.36	0.62	0.44	3.63	0.03*
Rheumatoid arthritis (hx)	0.13	0.054	0.37	0.27	0.03	0.22	0.18
Osteoarthritis (hx)	0.21	0.216	1.06	0.92	0.42	2.77	0.08
Psoriasis (hx)	0.04	0.029	0.76	0.85	0.08	2.17	0.53
Stroke (hx)	0.03	0.056	1.94	0.59	0.03	0.97	0.98
Current cigarette smoker	0.47	0.47	1.00	1.00	0.33	0.56	0.23
Statin use	0.19	0.16	0.78	0.68	0.33	2.07	0.19
Coronary heart disease (hx)	0.19	0.211	1.10	0.86	0.39	2.64	0.07
Metabolic syndrome1	0.36	0.611	2.78	0.03*	0.70	2.12	0.12
Diabetes2	0.10	0.256	3.02	0.08	0.54	10.29	0.00**
Hypertension3	0.39	0.632	2.63	0.04*	0.69	3.48	0.01*
Hepatitis B (assay)	0.05	0.000	0.00	0.99	0.03	0.51	0.59
Hepatitis C (assay)	0.21	0.132	0.57	0.36	0.08	0.34	0.13

Note: hx = by structured medical history; OR = Odds ratio

¹ATP-III⁴⁸

²Fasting glucose ≥ 140 mg/dL, medication for diabetes, or self-report

³Measured blood pressure ≥ 140/90, anti-hypertensive medication, or self-report

^*p<.05;

^**p<.01